Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the oncology therapeutics. Its lead product CYT-0851, an oral investigational drug that inhibits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results